Daliresp indications?

See the DrugPatentWatch profile for Daliresp

What is Daliresp (roflumilast) approved for?

Daliresp (roflumilast) is prescribed to lower the risk of COPD exacerbations in people with severe COPD associated with chronic bronchitis who have frequent exacerbations (as defined in the product’s prescribing information) [1].

Which COPD patients are considered the right fit?

Daliresp is aimed at people with:
- Severe COPD
- Chronic bronchitis symptoms
- A history of frequent exacerbations despite standard therapy [1]

Is Daliresp used for asthma?

No. Daliresp is indicated for COPD, not asthma [1].

Can Daliresp be used to treat sudden flare-ups?

Daliresp is not a rescue medication for acute shortness-of-breath episodes. It is used for maintenance to help reduce the likelihood of exacerbations over time [1].

What related uses might people search for?

People often search whether roflumilast (Daliresp) is used for:
- Emphysema without chronic bronchitis: the indication specifically targets COPD with chronic bronchitis and frequent exacerbations [1]
- “Frequent exacerbations” definition: the prescribing information ties this to exacerbation frequency in the clinical trial/program context used for labeling [1]

Sources

[1] https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=...